首页> 外国专利> Combined cholesterol and bilirubin tests as risk predictors for coronary artery disease

Combined cholesterol and bilirubin tests as risk predictors for coronary artery disease

机译:胆固醇和胆红素联合测试可预测冠状动脉疾病的风险

摘要

A new method for predicting the risk of coronary artery disease (CAD) is disclosed. The method uses a ratio made up of the levels of an individuals LDL-cholesterol (LDL-C), HDL-cholesterol (HDL-C) and serum total bilirubin (bilirubin). The ratio, using a weighted value for bilirubin, is LDL-C/(HDL-C+bilirubin).
机译:公开了一种预测冠状动脉疾病(CAD)风险的新方法。该方法使用由个体LDL-胆固醇(LDL-C),HDL-胆固醇(HDL-C)和血清总胆红素(bilirubin)水平组成的比率。使用胆红素的加权值的比率为LDL-C /(HDL-C +胆红素)。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号